INDOCO REMEDIES LTD. - Board Meeting Outcome for Outcome Of Board Meeting Held On 23Rd July, 2024

Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 23rd July, 2024 has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2024 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.